Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
September 16, 2025
Therapeutic Potential BPC-157 is modified for greater stability than its parent compound and is shown to have systemic effects without the need for a carrier agent
Can I do the Wolverine Stack entirely through telehealth
Animal Toxicology Studies Animal toxicology studies tested doses from 0.0027 mg/lb to 9.1 mg/lb via intraperitoneal, intramuscular, intravenous, and oral routes for up to 6 weeks, finding: No acute toxic or lethal dose No gross or histologic toxicity in major organs No hepatotoxicity or nephrotoxicity Negative Ames test (no mutagenicity) Negative chromosomal aberration tests (no genotoxicity) No teratogenicity in rat pregnancy studies No local injection site irritation The LD1 (minimum lethal dose) could not be achieved despite aggressive testing
TB-500's parent Thymosin -4 has been administered at micrograms-per-kilogram parenteral dosing in cardiac and corneal model systems
